Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
Cancer Medicine|July 23, 2024
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wallMadhumeeta Chadha, Sara Iadecola, Andrew Jenks, et al.
Cancers|July 2, 2021
The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort StudyAnne-Rose W Schut, Milea J M Timbergen, Emma Lidington, et al.
Clinical Sarcoma Research|September 22, 2016
Current status and unanswered questions on the use of Denosumab in giant cell tumor of boneCzar Louie Gaston, Robert J Grimer, Michael Parry, et al.
The Oncologist|December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal TumorsCissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
EJNMMI Research|January 14, 2021
The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)Luigi Aloj, Olivier Giger, Iosif A Mendichovszky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2023
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 StudiesMichael C Heinrich, Xinhua Zhang, Robin L Jones, et al.
BMC Cancer|December 13, 2022
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trialPatrick Schöffski, Suzanne George, Michael C Heinrich, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2021
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trialRobin L Jones, César Serrano, Margaret von Mehren, et al.
Annals of Surgical Oncology|September 19, 2019
Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active SurveillanceWinan J van Houdt, Olga Husson, Alisha Patel, et al.
Pageof 37